ArticleAmerican journal of cancer research2026
NCCRP1 promotes ovarian cancer progression and is associated with activation of the PI3K/AKT/mTOR signaling pathway and altered mitochondrial respiration.
Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-specific cytotoxic cell receptor protein 1 (NCCRP1) is a membrane protein involved in cell proliferation, but its role in ovarian cancer (OC) progression remains unclear. In this study, a prognostic model for OC was constructed using LASSO-penalized Cox regression analysis. NCCRP1 expression in ovarian tissues was detected by immunohistochemical staining, and its associations with clinicopathological features and prognosis were analyzed. The effects and underlying mechanism of NCCRP1 on the malignant biological behaviors of OC cells were further investigated in vitro and in vivo. The prognostic model consisted of 28 genes with significant prognostic value. Among these genes, NCCRP1 mRNA showed differential expression in ovarian tissues and potential prognostic significance. NCCRP1 protein was overexpressed in OC tissues compared with adjacent ovarian tissues, and high NCCRP1 expression was associated with ascites, tumor cells in ascites, lymph node metastasis, distant metastasis and advanced FIGO stage. Patients with high NCCRP1 expression tended to have poorer overall survival. Knockdown of NCCRP1 inhibited the proliferation, migration and invasion of OC cells and promoted apoptosis, whereas NCCRP1 overexpression produced the opposite effects. In addition, NCCRP1 knockdown decreased oxygen consumption rate, whereas NCCRP1 overexpression produced the opposite effect. NCCRP1 expression was also positively associated with the phosphorylation levels of PI3K, AKT and mTOR. These findings suggest that NCCRP1 promotes malignant biological behaviors in OC, is associated with altered mitochondrial respiratory activity and may exert its tumor-promoting effects, at least in part, through activation of the PI3K/AKT/mTOR signaling pathway. Therefore, NCCRP1 may serve as a novel prognostic marker and potential therapeutic target for OC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.